Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort.

Janet L KwiatkowskiThalassemia Clinical Research Network


Morbidity and mortality in thalassemia are associated with iron burden. Recent advances in organ-specific iron imaging and the availability of oral deferasirox are expected to improve clinical care, but the extent of use of these resources and current chelation practices have not been well described. In the present study, we studied chelation use and the change in iron measurements in 327 subjects with transfusion-dependent thalassemia (mean entry age, 22.1 ± 2.5 years) from 2002-2011, with a mean follow-up of 8.0 years (range, 4.4-9.0 years). The predominant chelator currently used is deferasirox, followed by deferoxamine and then combination therapies. The use of both hepatic and cardiac magnetic resonance imaging increased more than 5-fold (P < .001) during the study period, leading to an 80% increase in the number of subjects undergoing liver iron concentration (LIC) measurements. Overall, LIC significantly improved (median, 10.7 to 5.1 mg/g dry weight, P < .001) with a nonsignificant improvement in cardiac T2* (median, 23.55 to 34.50 ms, P = .23). The percentage of patients with markers of inadequate chelation (ferritin > 2500 ng/mL, LIC > 15 mg/g dry weight, and/or cardiac T2* < 10 ms) also declined from 33% to 26%. In su...Continue Reading


Jun 20, 1985·The New England Journal of Medicine·L WolfeD G Nathan
Sep 1, 1994·The New England Journal of Medicine·N F OlivieriA R Cohen
Jan 1, 1996·Acta Haematologica·V Gabutti, A Piga
Mar 27, 2002·European Heart Journal·L J AndersonDudley J Pennell
Jun 20, 2003·Journal of Magnetic Resonance Imaging : JMRI·Mark A WestwoodDudley J Pennell
Jul 9, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·John M AkuduguRichard P Hill
Dec 13, 2005·Annals of the New York Academy of Sciences·Dudley J Pennell
Jul 25, 2008·Blood·Leila J NoetzliJohn C Wood
Sep 27, 2008·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Bernadette ModellDudley J Pennell
Sep 8, 2009·Journal of Pediatric Hematology/oncology·Ofelia AlvarezCarole Paley
Aug 14, 2010·Blood·Gunnar JuliussonHelen Hallböök


Mar 25, 2014·European Journal of Pediatrics·Jelena RasconTadas Zvirblis
Dec 30, 2015·Pediatric Blood & Cancer·Charles T Quinn, Tim G St Pierre
Nov 7, 2015·Annals of Medicine·Farzana A Sayani, Janet L Kwiatkowski
Nov 19, 2013·Pediatric Clinics of North America·Hannah M Ware, Janet L Kwiatkowski
Jan 26, 2016·Critical Reviews in Oncology/hematology·John B PorterNorbert Gattermann
Feb 17, 2015·European Journal of Haematology·Rodolfo CançadoSamir K Ballas
Dec 1, 2012·La Revue de médecine interne·M Ruivard
Nov 1, 2015·Clinical Therapeutics·C Borgna-Pignatti, Maria Marsella
Jun 13, 2013·American Journal of Hematology·Alexis ThompsonThalassemia Clinical Research Network
Jan 3, 2013·British Journal of Haematology·Dru HainesThalassemia Clinical Research Network
Jan 24, 2014·American Journal of Hematology·John C WoodEllis Neufeld
Mar 22, 2014·British Journal of Haematology·Yesim AydinokVip Viprakasit
Mar 22, 2014·American Journal of Hematology·Diana X Nichols-VinuezaEllis Neufeld
Jun 4, 2014·International Journal of Nursing Practice·Manal Ibrahim Al-KloubErika Sivarajan Froelicher
Jan 17, 2013·Hematology·Vedat Uygun, Erdal Kurtoglu
Aug 15, 2014·Pediatric Hematology and Oncology·Manal Ibrahim Al-KloubErika Sivarajan Froelicher
Jul 23, 2015·Journal of Pediatric Hematology/oncology·Venée N TubmanThalassemia Clinical Research Network
Aug 25, 2012·Blood·A V HoffbrandMaria Domenica Cappellini
Aug 4, 2012·Blood·Peter W Marks
May 18, 2016·Annals of the New York Academy of Sciences·Janet L Kwiatkowski
May 21, 2016·Clinical Journal of Oncology Nursing·M B Martin, Drucilla Haines
Apr 23, 2016·Archives of Disease in Childhood·Melpomeni Rompola
Jun 20, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sonali ChaudhuryShalini Shenoy
Feb 21, 2018·Journal of Pediatric Hematology/oncology·Huda GharaibehMohammed Al Bashtawy
Jun 19, 2013·Circulation·Dudley J PennellAmerican Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology and Council
Sep 5, 2020·European Journal of Haematology·Antonis KattamisVip Viprakasit
Aug 11, 2016·British Journal of Haematology·Sherif M BadawyAlexis Thompson
Sep 16, 2020·Archives of Osteoporosis·Pokpong PiriyakhuntornNipon Chattipakorn
Jun 10, 2017·BioMed Research International·Muzaheed Abdul RasheedSaeed Sattar Shaikh
May 1, 2021·Tomography : a Journal for Imaging Research·Narumol ChaosuwannakitChinnadol Wanitpongpun

Related Concepts

Homo sapiens
Iron Chelating Agents
Longitudinal Survey
Magnetization Transfer Contrast Imaging
Northern America

Related Feeds


Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.